Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2010
06/03/2010WO2010061185A2 Therapeutic target
06/03/2010WO2010060967A2 Compositions and methods for treating retrovirus infections
06/03/2010WO2010060636A1 Antimicrobial therapy
06/03/2010WO2010060200A1 Bacteriophage compositions for treatment of bacterial infections
06/03/2010WO2010046572A8 Antiviral composition
06/03/2010WO2010042392A3 Hiv integrase inhibitors
06/03/2010WO2010042391A3 Hiv integrase inhibitors
06/03/2010WO2010037785A3 Inhibitors of f18+ e coli binding
06/03/2010WO2010035226A3 Herbal composition and method for the treatment of viral infection
06/03/2010WO2010033863A3 Vaccine compositions of m2e, ha0 and bm2 multiple antigenic peptides
06/03/2010WO2010033219A3 Protease inhibitors having enhanced features
06/03/2010WO2010027501A3 Anti-lipid antibodies
06/03/2010WO2009100351A3 Delivery of rnai constructs to oligodendrocytes
06/03/2010WO2009052090A8 Silicate containing compositions and methods of treatment
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137566 Compounds and Methods Used to Treat Infectious Diseases
06/03/2010US20100137451 Compositions and methods for treating hoof diseases
06/03/2010US20100137437 Composition for Inactivating an Enveloped Virus
06/03/2010US20100137431 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses
06/03/2010US20100137415 Vector for gene therapy
06/03/2010US20100137412 Lentivirus pseudotyped with influenza hemagglutinin and methods of use
06/03/2010US20100137408 Antisense antibacterial method and compound
06/03/2010US20100137407 Single-chain circular rna and method of producing the same
06/03/2010US20100137388 Therapeutic Pro-Antibiotic Agents and Methods of Use Thereof
06/03/2010US20100137365 Long chain N-alkyl compounds and oxa-derivatives thereof
06/03/2010US20100137359 Caspase inhibitors and uses thereof
06/03/2010US20100137355 Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
06/03/2010US20100137353 Tricyclic compounds as antibacterials
06/03/2010US20100137350 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them
06/03/2010US20100137349 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
06/03/2010US20100137345 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
06/03/2010US20100137333 Antifungal composition and methods for using
06/03/2010US20100137319 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
06/03/2010US20100137308 Quinoxaline Compounds and Use Thereof
06/03/2010US20100137303 New compound 255
06/03/2010US20100137290 Oxazolidinone antibiotic derivatives
06/03/2010US20100137282 Tricyclic nitrogen containing compounds as antibacterial agents
06/03/2010US20100137275 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
06/03/2010US20100137272 Zinc Salt Of Isothiazolone Compound, Method For Reducing Irritation Caused By Isothiazolone Compound, Antibacterial and Antifungal Method Using Zinc Salt of Isothiazolone Compound, and Antibacterial and Antifungal Composition
06/03/2010US20100137248 Boron-containing compounds, uses and preparation thereof
06/03/2010US20100137243 Oxazolidinone And/Or Isoxazoline As Antibacterial Agents
06/03/2010US20100137240 Use of nucleoside derivatives as anti-koi herpes virus in fish
06/03/2010US20100137237 Process for the preparation of an (rp)-8-substituted camps
06/03/2010US20100137234 10-substituted macrolide antibiotics
06/03/2010US20100137232 Composition comprising a diuretic and a cardiac glycoside for the treatment of dna viral infections of the eye
06/03/2010US20100137230 New pyridin-2-one compounds
06/03/2010US20100137199 Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME
06/03/2010US20100137198 Pharmaceutical composition for topical application
06/03/2010US20100137193 Chitosan derivatives to treat animals or optimize animal health
06/03/2010US20100137192 Compositions and methods for treating or ameliorating mycobacterial infections
06/03/2010US20100136695 Double-stranded oligonucleotides
06/03/2010US20100136662 Endotoxin binding by lactic acid bacteria and bifidobacteria
06/03/2010US20100136628 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136122 Oral Preparation Comprising Pioglitazone
06/03/2010US20100136106 Modified Release Famciclovir Compositions
06/03/2010US20100136092 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same
06/03/2010US20100136089 Location of fatty acid esters on tampons and toxin inhibiting efficacy
06/03/2010US20100136080 Material depot for releasing an antibacterial active agent
06/03/2010US20100136072 Polymeric Coatings that Inactivate Viruses and Bacteria
06/03/2010US20100136060 Methods of reducing porcine circovirus-associated disease outbreaks
06/03/2010US20100136059 Hybrid operon for expression of colonization factor (cf) antigens of enterotoxigenic escherichia coli
06/03/2010US20100136057 Virulence of streptococci
06/03/2010US20100136056 Novel insertion sites in pox vectors
06/03/2010US20100136055 Chimeric pestiviruses
06/03/2010US20100136054 Flavivirus ns1 subunit vaccine
06/03/2010US20100136051 N Protein Muants of Porcine Reproductive and Respiratory Syndrome Virus
06/03/2010US20100136049 Methods and compositions for vaccination of poultry
06/03/2010US20100136048 Live bacterial vaccines resistant to carbon dioxide (co2), acidic ph and/or osmolarity for viral infection prophylaxis or treatment
06/03/2010US20100136047 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use
06/03/2010US20100136046 Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
06/03/2010US20100136044 Dietary Supplement and Method
06/03/2010US20100136043 Composition comprising immunogenic microparticles
06/03/2010US20100136040 Use of the 7f4 protein in the in vitro diagnosis of mycoplasma pneumoniae infections
06/03/2010US20100136039 Borrelia antigens
06/03/2010US20100136038 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
06/03/2010US20100136036 Unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
06/03/2010US20100136027 Methods and Compositions for Treating Bacterial Infection
06/03/2010US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/2010US20100136016 Heat shock proteins from mycobacterium leprae and uses thereof
06/03/2010US20100136010 Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
06/03/2010US20100135999 Quinoline-carboxamide derivatives as p2y12 antagonists
06/03/2010US20100135997 Polypeptide monomers and dimers containing mutated ilt
06/03/2010US20100135989 Anti-hiv agents
06/03/2010US20100135983 Anti-inflammatory compositions and methods
06/03/2010US20100135966 Agents for treating flaviviridae infections
06/03/2010US20100135962 Novel Bacteriophage and Antibacterial Composition Comprising the Same
06/03/2010US20100135961 Live bacterial vaccines resistant to carbon dioxide (co2), acidic ph and/or osmolarity for viral infection prophylaxis or treatment
06/03/2010US20100135960 Antiviral acylsulfonamide derivatives
06/03/2010US20100135955 HUMAN M2e PEPTIDE IMMUNOGENS
06/03/2010US20100135926 Antimicrobial and immunostimulatory system comprising an oxidoreductase enzyme
06/03/2010US20100135919 Proteolytic enzyme formulations
06/03/2010US20100135901 Combination therapy
06/03/2010CA2779413A1 Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth
06/03/2010CA2744909A1 Bacteriophage compositions for treatment of bacterial infections
06/03/2010CA2744705A1 Compositions and methods for treating hoof diseases
06/03/2010CA2744355A1 Compositions and methods for treating retrovirus infections
06/02/2010EP2192190A1 Yogurt containing pectin hydrolysis products
06/02/2010EP2192131A1 Immunoglobulins devoid of light chains
06/02/2010EP2191890A1 Process for producing fine particles and the fine particles
1 ... 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 ... 1798